Effect of the interaction between BDNF Val66Met polymorphism and daily physical activity on mean diffusivity.


Journal

Brain imaging and behavior
ISSN: 1931-7565
Titre abrégé: Brain Imaging Behav
Pays: United States
ID NLM: 101300405

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 9 1 2019
medline: 28 4 2021
entrez: 9 1 2019
Statut: ppublish

Résumé

Numerous studies have reported that the Met allele of the brain-derived neurotrophic factor (BDNF) gene polymorphism reduces neural plasticity. A reduction in mean diffusivity (MD) in diffusion tensor imaging (DTI) characteristically reflects the neural plasticity that involves increased tissue components. In this study, we revealed that the number of Met-BDNF alleles was negatively associated with MD throughout the whole-brain gray and white matter areas of 743 subjects using DTI and whole-brain multiple regression analyses. Within the same sample, the region of interest analysis revealed that the number of Met-BDNF alleles significantly and positively correlated with the mean FA value in the body of the corpus callosum. In addition, we observed interaction effects between BDNF Val66Met polymorphism and daily physical activity levels on MD, but not FA, in significant clusters of the bilateral hemisphere (n = 577 subjects). Post-hoc multiple regression analyses revealed that after correcting for confounding variables, there was a significant negative correlation between the physical activity level and mean MD of the whole brain in the Val/Val group [standardized partial regression coefficient (β) = -0.196, P = 0.005, t = -2.825], but not in the Val/Met (β = 0.050, P = 0.412, t = 0.822) and Met/Met groups (β = 0.092, P = 0.382, t = 0.878). These results underscore the importance of the interaction between physical activity and the BDNF Val66Met polymorphism, which affects the plasticity of neural mechanisms.

Identifiants

pubmed: 30617785
doi: 10.1007/s11682-018-0025-8
pii: 10.1007/s11682-018-0025-8
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

806-820

Subventions

Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : KAKENHI 23700306
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : KAKENHI 25700012

Auteurs

Hikaru Takeuchi (H)

Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-cho, Aoba-ku, Sendai, 980-8575, Japan. takehi@idac.tohoku.ac.jp.

Hiroaki Tomita (H)

Department of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.

Yasuyuki Taki (Y)

Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-cho, Aoba-ku, Sendai, 980-8575, Japan.
Division of Medical Neuroimage Analysis, Department of Community Medical Supports, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Department of Nuclear Medicine and Radiology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Yoshie Kikuchi (Y)

Department of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.

Chiaki Ono (C)

Department of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.

Zhiqian Yu (Z)

Department of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.

Atsushi Sekiguchi (A)

Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

Rui Nouchi (R)

Human and Social Response Research Division, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.

Yuka Kotozaki (Y)

Smart Ageing International Research Center, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Seishu Nakagawa (S)

Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Carlos Makoto Miyauchi (CM)

Graduate School of Arts and Sciences, Department of General Systems Studies, The University of Tokyo, Tokyo, Japan.

Kunio Iizuka (K)

Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Department of Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan.

Ryoichi Yokoyama (R)

Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Japan Society for the Promotion of Science, Tokyo, Japan.

Takamitsu Shinada (T)

Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Yuki Yamamoto (Y)

Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Sugiko Hanawa (S)

Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Tsuyoshi Araki (T)

Smart Ageing International Research Center, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Keiko Kunitoki (K)

Faculty of Medicine, Tohoku University, Sendai, Japan.

Yuko Sassa (Y)

Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-cho, Aoba-ku, Sendai, 980-8575, Japan.

Ryuta Kawashima (R)

Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-cho, Aoba-ku, Sendai, 980-8575, Japan.
Smart Ageing International Research Center, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH